“Clinical Outcomes and Pathogenetic Mechanisms of Adjunctive Ribonucleic Acid Therapy in Adult Patients With Measles During the Period of Increased Incidence in 2025–2026”. 2026. Infectious Diseases – Infektsiyni Khvoroby, no. 3 (September): 13-26. https://doi.org/10.11603/1681-2727.2026.3.16753.